Fritextsökning
Innehållstyper
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Xvivo byter vd
Dag Andersson tar över vd-rollen efter grundaren Magnus Nilsson.
-
Studie: Barn har oftare antikroppar som korsreagerar med coronaviruset
Enligt en ny studie förekommer det ibland antikroppar hos personer som inte haft covid-19 som korsreagerar med det nya coronaviruset sars-cov-2.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Patientmakt i fokus på digitalt möte
Internet har inneburit att relationen mellan patient och läkare fått ny betydelse. Det är ett av ämnena som diskuteras under mötet Digital Health Days i Stockholm.
-
Ny chef på Oncopeptides
Rekryterar från Sobi.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Angelica Loskog: ”Som barn var jag jättefixerad vid cancer. Där började mitt intresse”
Life Science Sweden vill veta mer om Angelica Loskog och ställer frågor om hennes liv som forskare.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Satsar på tidig forskning
Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New management at Øresund
The Øresund University has recently appointed a new director and a new Chairman.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Positiva resultat för nytt läkemedel mot ovanlig blodsjukdom
Läkemedlet pegcetacoplan förbättrade tillståndet hos patienter vid den allvarliga och svårbehandlade sjukdomen PNH, enligt en studie.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
BREAKING